184 related articles for article (PubMed ID: 18205980)
21. Dopamine inhibits somatolactin gene expression in tilapia pituitary cells through the dopamine D2 receptors.
Jiang Q; Lian A; He Q
Comp Biochem Physiol A Mol Integr Physiol; 2016 Jul; 197():35-42. PubMed ID: 26970582
[TBL] [Abstract][Full Text] [Related]
22. Bradykinin inhibits cyclic AMP accumulation in D384-human astrocytoma cells via a calcium-dependent inhibition of adenylyl cyclase.
Altiok N; Fredholm BB
Cell Signal; 1993 May; 5(3):279-88. PubMed ID: 7688545
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of AC-II activity following chronic agonist exposure is modulated by phosphorylation.
Schallmach E; Steiner D; Vogel Z
J Mol Neurosci; 2006; 29(2):115-22. PubMed ID: 16954601
[TBL] [Abstract][Full Text] [Related]
24. Modulation of adenylyl cyclase activity in rat striatal homogenate by dopaminergic receptors.
Vonk A; Reinart R; Rinken A
J Pharmacol Sci; 2008 Sep; 108(1):63-70. PubMed ID: 18818481
[TBL] [Abstract][Full Text] [Related]
25. Transfected D2 dopamine receptors mediate the potentiation of arachidonic acid release in Chinese hamster ovary cells.
Kanterman RY; Mahan LC; Briley EM; Monsma FJ; Sibley DR; Axelrod J; Felder CC
Mol Pharmacol; 1991 Mar; 39(3):364-9. PubMed ID: 1848657
[TBL] [Abstract][Full Text] [Related]
26. The atypical dopamine D1 receptor agonist SKF 83959 induces striatal Fos expression in rats.
Wirtshafter D; Osborn CV
Eur J Pharmacol; 2005 Dec; 528(1-3):88-94. PubMed ID: 16324697
[TBL] [Abstract][Full Text] [Related]
27. Decreased type VI adenylyl cyclase mRNA concentration and Mg(2+)-dependent adenylyl cyclase activities and unchanged type V adenylyl cyclase mRNA concentration and Mn(2+)-dependent adenylyl cyclase activities in the left ventricle of rats with myocardial infarction and longstanding heart failure.
Espinasse I; Iourgenko V; Richer C; Heimburger M; Defer N; Bourin MC; Samson F; Pussard E; Giudicelli JF; Michel JB; Hanoune J; Mercadier JJ
Cardiovasc Res; 1999 Apr; 42(1):87-98. PubMed ID: 10434999
[TBL] [Abstract][Full Text] [Related]
28. Dopamine receptor activation in bovine pinealocyte via a cAMP-dependent transcription pathway.
Santanavanich C; Ebadi M; Govitrapong P
J Pineal Res; 2005 Apr; 38(3):170-5. PubMed ID: 15725338
[TBL] [Abstract][Full Text] [Related]
29. Adenylyl cyclase types I and VI but not II and V are selectively inhibited by nitric oxide.
Goldstein J; Silberstein C; Ibarra C
Braz J Med Biol Res; 2002 Feb; 35(2):145-51. PubMed ID: 11847517
[TBL] [Abstract][Full Text] [Related]
30. Isoform selectivity of adenylyl cyclase inhibitors: characterization of known and novel compounds.
Brand CS; Hocker HJ; Gorfe AA; Cavasotto CN; Dessauer CW
J Pharmacol Exp Ther; 2013 Nov; 347(2):265-75. PubMed ID: 24006339
[TBL] [Abstract][Full Text] [Related]
31. Dopamine stimulates K+ efflux in the chick retina via D1 receptors independently of adenylyl cyclase activation.
Laitinen JT
J Neurochem; 1993 Oct; 61(4):1461-9. PubMed ID: 8397294
[TBL] [Abstract][Full Text] [Related]
32. Dopamine-dependent cyclic AMP generating system in chick retina and its relation to melatonin biosynthesis.
Zawilska JB; Derbiszewska T; Sek B; Nowak JZ
Neurochem Int; 1995 Dec; 27(6):535-43. PubMed ID: 8574183
[TBL] [Abstract][Full Text] [Related]
33. Differential involvement of cyclase- versus non-cyclase-coupled D1-like dopamine receptors in orofacial movement topography in mice: studies with SKF 83822.
Makihara Y; Okuda Y; Kawada C; Matsumoto M; Waddington JL; Koshikawa N; Tomiyama K
Neurosci Lett; 2007 Mar; 415(1):6-10. PubMed ID: 17234342
[TBL] [Abstract][Full Text] [Related]
34. Ethanol's actions on cAMP-mediated signaling in cells transfected with type VII adenylyl cyclase.
Yoshimura M; Tabakoff B
Alcohol Clin Exp Res; 1999 Sep; 23(9):1457-61. PubMed ID: 10512310
[TBL] [Abstract][Full Text] [Related]
35. Opiate-induced adenylyl cyclase superactivation is isozyme-specific.
Avidor-Reiss T; Nevo I; Saya D; Bayewitch M; Vogel Z
J Biol Chem; 1997 Feb; 272(8):5040-7. PubMed ID: 9030567
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of cloned adenylyl cyclases by mutant-activated Gi-alpha and specific suppression of type 2 adenylyl cyclase inhibition by phorbol ester treatment.
Chen J; Iyengar R
J Biol Chem; 1993 Jun; 268(17):12253-6. PubMed ID: 8389756
[TBL] [Abstract][Full Text] [Related]
37. Adenylyl cyclase type II activity is regulated by two different mechanisms: implications for acute and chronic opioid exposure.
Schallmach E; Steiner D; Vogel Z
Neuropharmacology; 2006 Jun; 50(8):998-1005. PubMed ID: 16545401
[TBL] [Abstract][Full Text] [Related]
38. Inhibition and superactivation of the calcium-stimulated isoforms of adenylyl cyclase: role of Gbetagamma dimers.
Steiner D; Avidor-Reiss T; Schallmach E; Saya D; Vogel Z
J Mol Neurosci; 2005; 27(2):195-203. PubMed ID: 16186630
[TBL] [Abstract][Full Text] [Related]
39. D2 dopamine receptor-induced sensitization of adenylyl cyclase type 1 is G alpha(s) independent.
Vortherms TA; Nguyen CH; Bastepe M; Jüppner H; Watts VJ
Neuropharmacology; 2006 Apr; 50(5):576-84. PubMed ID: 16376953
[TBL] [Abstract][Full Text] [Related]
40. Determination of D1 and D2 dopamine receptor expression by Ntera-2 cells.
Sakolsky DJ; Ashby B
Brain Res Mol Brain Res; 2000 Dec; 84(1-2):158-61. PubMed ID: 11113544
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
